Global Alzheimer’s Treatment Market Size to Grow at a CAGR of 7.2% During the Forecast Period of 2023-2031

Alzheimer's Treatment Market

The ‘Global Alzheimer’s Treatment Market Size, Share, Industry, Analysis, Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook of the global Alzheimer’s treatment market, assessing the market on the basis of its segments like drug class, diagnosis, therapeutic channel, age group, end user and major regions.

The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.

Alzheimer’s Treatment Market Size, Share, Trends, Industry Report, Key Player, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2016-2031)

• Forecast CAGR (2023-2031): 7.2 %
• Forecast Market Size (2031): 80.2 billion

The growth of the Alzheimer’s treatment market is driven by factors such as the increasing prevalence of Alzheimer’s disease, growing geriatric population, and ongoing research and development in the field of Alzheimer’s treatment. The market growth is also driven by the rising awareness about Alzheimer’s disease and the importance of early diagnosis and treatment among patients and healthcare providers.


The market development is further driven by the increasing adoption of Alzheimer’s treatment drugs by healthcare providers and the growing number of government initiatives and public-private partnerships to promote research and development in Alzheimer’s treatment. However, the high cost of drug development and the limited availability of effective treatments for Alzheimer’s disease are expected to restrain the growth of the market.

Overall, the increasing prevalence of Alzheimer’s disease and the growing geriatric population are expected to drive the market for Alzheimer’s treatment. The ongoing research and development, increasing adoption of Alzheimer’s treatment drugs by healthcare providers, and the growing awareness about Alzheimer’s disease are also expected to drive the market growth.

Alzheimer’s Treatment Market Segmentation

Alzheimer’s treatment primarily includes medications that help manage the symptoms of the disease, such as memory loss, confusion, and behavioural changes. The current drugs available in the market are categorized into two classes: cholinesterase inhibitors and NMDA receptor antagonists. These drugs work by regulating the levels of neurotransmitters in the brain, which play a crucial role in memory and cognitive function.


Market Breakup by Drug Class

• Cholinesterase Inhibitors
• NMDA Receptor Antagonists

Based on diagnosis, the market is bifurcated into

• Psychometric Diagnosis
• Cerebrospinal Fluid Analysis

Based on Age, the market is classified into

• Adults
• Childrens

Market Breakup by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Alzheimer’s Treatment Market Trends

Recent developments in the Alzheimer’s treatment market include ongoing research in the development of new drugs and therapies targeting the underlying causes of Alzheimer’s disease, such as the accumulation of amyloid-beta plaques and tau tangles in the brain. There is also a growing interest in the use of biomarkers for early diagnosis and personalized treatment of Alzheimer’s disease. Advances in neuroimaging and genetics are expected to play a crucial role in the development of new Alzheimer’s treatments in the future.

Growing acceptance of early diagnosis and intervention strategies for Alzheimer’s disease is also aiding the market growth. Early diagnosis can help patients and their families to plan, access appropriate care, and enrol in clinical trials for potential new treatments.

Key Market Players

The major players in the Alzheimer’s treatment market report include

• Allergan
• Eisai Co. Ltd.
• Janssen Pharmaceuticals, Inc.
• Novartis International AG
• Pfizer Inc.
• H. Lundbeck A/S
• AstraZeneca
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company.
• Others

The report covers the market shares, capacities, plant turnarounds, expansions, investments, and mergers and acquisitions, among other latest developments of these market players.

Leave a Reply